Search research articles
Contact Us
Filters
Showing results (31-40 of 87) with videos related to
Page
of 9
Sort By:
Clinical Pharmacokinetics
|
May 1, 1987
Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update
J G Riddell, D W Harron, R G Shanks
British Journal of Clinical Pharmacology
|
February 1, 1985
Indoramin-prolongation of repolarization time, a mechanism of bradycardia in man?
D W Harron, D P Nicholls, R G Shanks
British Journal of Clinical Pharmacology
|
January 1, 1983
Cardiovascular effects of indoramin in man--a dose ranging study
D P Nicholls, D W Harron, R G Shanks
Family Practice
|
April 1, 1996
Paracetamol prescribing--an epidemic?
K P Dawson, S McIlvenny, S Quinn, et al.
Drugs
|
May 1, 1992
Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias
D W Harron, R N Brogden, D Faulds, et al.
Pflugers Archiv : European Journal of Physiology
|
January 23, 1999
The effects of oxytocin on the pattern of electrical propagation in the isolated pregnant uterus of the rat
W J Lammers, B Stephen, R Hamid, et al.
British Journal of Clinical Pharmacology
|
October 1, 1983
An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine
D W Harron, D Arndts, M Finch, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1990
UK-52,046 (a novel alpha 1-adrenoceptor antagonist) and the role of alpha-adrenoceptor stimulation and blockade on atrioventricular conduction
J P Spiers, D W Harron, R Wilson, et al.
Arzneimittel-Forschung
|
January 1, 1985
Effect of 8-(3-diethylaminopropyl)-6,6-dimethyl-(2-phenyl-1 H-imidazo(4,5 h))isoquinoline-7,9-(6H)-dione dihydrochloride (AR-LH31) on experimental cardiac arrhythmias in dogs
M J Kerr, D W Harron, R Wilson, et al.
Journal of Cardiovascular Pharmacology
|
March 1, 1982
Effects of alinidine, a novel bradycardic agent, on heart rate and blood pressure in man
D W Harron, K Jady, J G Riddell, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 87) with videos related to
Sort By:
Page
of 9
Clinical Pharmacokinetics
|
May 1, 1987
Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update
J G Riddell, D W Harron, R G Shanks
British Journal of Clinical Pharmacology
|
February 1, 1985
Indoramin-prolongation of repolarization time, a mechanism of bradycardia in man?
D W Harron, D P Nicholls, R G Shanks
British Journal of Clinical Pharmacology
|
January 1, 1983
Cardiovascular effects of indoramin in man--a dose ranging study
D P Nicholls, D W Harron, R G Shanks
Family Practice
|
April 1, 1996
Paracetamol prescribing--an epidemic?
K P Dawson, S McIlvenny, S Quinn, et al.
Drugs
|
May 1, 1992
Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias
D W Harron, R N Brogden, D Faulds, et al.
Pflugers Archiv : European Journal of Physiology
|
January 23, 1999
The effects of oxytocin on the pattern of electrical propagation in the isolated pregnant uterus of the rat
W J Lammers, B Stephen, R Hamid, et al.
British Journal of Clinical Pharmacology
|
October 1, 1983
An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine
D W Harron, D Arndts, M Finch, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1990
UK-52,046 (a novel alpha 1-adrenoceptor antagonist) and the role of alpha-adrenoceptor stimulation and blockade on atrioventricular conduction
J P Spiers, D W Harron, R Wilson, et al.
Arzneimittel-Forschung
|
January 1, 1985
Effect of 8-(3-diethylaminopropyl)-6,6-dimethyl-(2-phenyl-1 H-imidazo(4,5 h))isoquinoline-7,9-(6H)-dione dihydrochloride (AR-LH31) on experimental cardiac arrhythmias in dogs
M J Kerr, D W Harron, R Wilson, et al.
Journal of Cardiovascular Pharmacology
|
March 1, 1982
Effects of alinidine, a novel bradycardic agent, on heart rate and blood pressure in man
D W Harron, K Jady, J G Riddell, et al.
Page
of 9